NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 283 filers reported holding NATERA INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,205 | -17.0% | 660 | -8.7% | 0.00% | 0.0% |
| Q2 2023 | $35,181 | -18.3% | 723 | -6.8% | 0.00% | 0.0% |
| Q1 2023 | $43,084 | +45.3% | 776 | +5.1% | 0.00% | 0.0% |
| Q4 2022 | $29,645 | -22.0% | 738 | -15.4% | 0.00% | -50.0% |
| Q3 2022 | $38,000 | +31.0% | 872 | +5.2% | 0.00% | +100.0% |
| Q2 2022 | $29,000 | +52.6% | 829 | +84.2% | 0.00% | 0.0% |
| Q1 2022 | $19,000 | +533.3% | 450 | +1185.7% | 0.00% | – |
| Q4 2021 | $3,000 | -89.3% | 35 | -86.0% | 0.00% | -100.0% |
| Q3 2021 | $28,000 | +133.3% | 250 | +129.4% | 0.00% | 0.0% |
| Q2 2021 | $12,000 | +100.0% | 109 | +75.8% | 0.00% | – |
| Q1 2021 | $6,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 62 | +313.3% | 0.00% | – |
| Q3 2020 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |